Abstract
The tumor microenvironment is increasingly understood to contribute to cancer development and progression by affecting the complex interplay of genetic and epigenetic changes within the cells themselves. Moreover, recent research has highlighted that, besides biochemical cues from the microenvironment, physical cues can also greatly alter cellular behavior such as proliferation, cancer stem cell properties, and metastatic potential. Whereas initial assays have focused on basic ECM physical properties, such as stiffness, novel in vitro systems are becoming increasingly sophisticated in differentiating between distinct physical cues—ECM pore size, fiber alignment, and molecular composition—and elucidating the different roles these properties play in driving tumor progression and metastasis. Combined with advances in our understanding of the mechanisms responsible for how cells sense these properties, a new appreciation for the role of mechanics in cancer is emerging.
Graphical Abstract
Introduction
Cancer has long been understood to arise through a sequence of mutations, leading to the acquisition of key hallmarks such as uncontrolled growth, evasion of apoptosis, and/or induction of angiogenesis [1]. Moreover, the majority of cancer-related deaths are caused not by the primary tumor, but by distant metastasis. Hence, the capability of cancer cells to become migratory and invade into surrounding tissues and distant organs is another crucial hallmark of cancer [1]. But cancer progression is more than just changes in the cancer cells themselves as changes in the tumor microenvironment have also been shown to play a critical role in tumor development and progression [2] as well as drug efficacy [3]. For example, stromal cells, such as fibroblasts [4] or immune cells [5], assist cancer at various stages of tumor development and dissemination. In addition, these stromal cells can work in concert with cancer cells to actively modify physical properties of the extracellular matrix (ECM) [6], which further contributes to tumor progression. Therefore, while cancer research has traditionally focused on biochemical mechanisms, recent studies have now begun to investigate the role of ECM physical properties, such as stiffness, pore size, and viscoelasticity. These advances in understanding also highlight the importance of representing these physical properties accurately in in vitro cultures.
Moreover, by appreciating the role of external physical forces on cellular behavior, a key resulting question is how do cells sense, and then integrate, these physical signals into specific behavioral changes? In addition, such behavioral changes can even include alterations in their own mechanical states. Whereas biochemical research has long focused on studying reaction kinetics, it is now understood that many molecules can undergo conformational changes when subjected to forces, exposing additional binding sites and changing the binding kinetics. Hence, molecular pathways and reactions are increasingly studied in the context of mechanical forces using tools and methods developed in the fields of mechanobiology and mechanotransduction.
In this perspective, we will first discuss the tumor microenvironment and how its properties affect tumor progression, migration, and metastasis. We will review recent advances in in vitro culture techniques that mimic this complex environment, and emphasize how these and future advances help to understand the different migratory strategies of cancer cells. We will then introduce some of the key intracellular molecules involved in mechanotransduction, illustrate current efforts to uncover the role of physical cues in directing cellular behavior, and comment on the technological advancements needed, in the immediate future, to probe these processes in depth. Finally, we will also highlight how microenvironmental properties may affect the maintenance and migratory capability of cancer stem cells, a highly tumorigenic subpopulation of cancer cells thought to be primarily responsible for tumor formation and propagation.
The Role of the Tumor Microenvironment in Cancer Cell Migration
Physical ECM properties
Recently, cancer research has focused on the role of physical ECM properties because the stiff tumor microenvironment—caused by tumor-associated ECM remodeling and characterized by increased ECM deposition, fiber alignment and crosslinking—has been shown to actively promote tumor progression and malignancy through increased integrin signaling [7]. This increased malignancy could be counteracted by softening the tumor microenvironment through the inhibition of lysyl oxidase (LOX), an enzyme that covalently crosslinks collagen and elastin in the ECM [8]. Conversely, in a separate study, normal mammary epithelial cells were shown to be driven towards a malignant phenotype by increased matrix stiffness alone [9*]; further illustrating the active role that ECM mechanical properties play in tumor progression.
In addition, ECM properties also influence cell migration behavior. For instance, key parameters in cell migration, such as cell speed, are crucially affected by matrix stiffness [10]. ECM properties also affect directional motility, as cells have long been known to preferentially migrate along 2D substrates from softer to stiffer environments in a process termed durotaxis [11]. While such behavior was reproduced when the 2D substrate was overlain with a 3D collagen matrix [12], recently developed approaches capable of generating 3D ECM stiffness gradients have revealed that cells, in some cases, are able to migrate from stiff to soft matrices in a process called “reverse durotaxis”[13,14]. Further investigation is required to understand this apparent plasticity in directional motility.
Besides stiffness, the ECM architecture itself can direct migratory behavior. For example, collagen fiber alignment is correlated with advanced progression [15], since alignment of fibers away from the tumor enables cancer cells to migrate persistently along those fibers [16**]. Furthermore, the higher mechanical resistance associated with increased ECM density has recently been shown to cause a shift to protease-dependent invasion [17], whereby ECM fibers are degraded by matrix metalloproteinases (MMPs). However, if MMPs are inhibited, cancer cells can switch to an MMP-independent mode of migration [18]. How MMPs and matrix realignment influences migration and relates to other parameters, such as stiffness or pore size, is an ongoing, active area of research [19**].
Increased confinement due to increased collagen concentration has also been shown to be associated with a switch from single to collective cell migration, with leader cells generating proteolytic tracks due to MMP activity [20*]. How collectively migrating cells depend on leader cells, or can self-organize, is itself an ongoing research effort [21]. This research also has potential clinical applications. For instance, if collective migration is largely driven by leader cells, then targeting the leader cell alone might be a promising strategy for preventing metastasis. Therefore, more work needs to be done to investigate which environmental factors drive collective cell migration, and in which situations leader cells emerge and become necessary for migration and metastasis. However, to effectively study how ECM physical properties direct cell migration, further advancements in 3D techniques are needed that can create tunable ECM gradients and vary individual ECM parameters (i.e. mechanical stiffness, ligand density, and fiber alignment) independently. To this end, recent advancements in material design have yielded synthetic fibrous materials, which not only have the desired tunability of synthetic materials, but also mimic the fibrillar structure of the native ECM [22**].
Hypoxia-driven Migration
Hypoxia has been shown to stimulate the epithelial-mesenchymal transition (EMT), and consequently cancer cell migration, through Notch signaling [23] and Snail-1 upregulation, a critical regulator of EMT. Snail-1 activity is increased by two different, but synergistic, Notch-mediated mechanisms: (1) the intracellular domain of Notch binds to the Snail-1 promoter and consequently increases its expression, and (2) Notch mediates the recruitment of hypoxia-inducible factor 1α (HIF-1α) to the lysyl oxidase (LOX) promoter, thereby elevating LOX expression, which, in addition to its role in crosslinking ECM molecules, stabilizes the Snail-1 protein. Furthermore, hypoxia can also lead to increases in collagen deposition and MMP production [24]. Therefore, hypoxia-driven ECM remodeling may also reinforce cancer cell migration by promoting an invasive phenotype [24,25].
External Mechanical Forces Promoting Migration
Recent evidence has shown that external mechanical forces also influence cancer cell migration. For example, compressive forces resulting from uncontrolled tumor growth have been found to promote an invasive phenotype. In a study using an in vitro 2D model, compressive forces applied to epithelial cell sheets generated a subset of “leader cells” that extended filopodia at the leading edge [26]. The development of these leader cells was acto-myosin independent and characterized by increased fibronectin deposition.
In addition, the compressive forces generated by uncontrolled tumor growth may lead to the collapse of lymphatics and small blood vessels [27], which is thought to elevate interstitial fluid pressure—an indicator of poor prognosis [28]—and drive interstitial flow. Furthermore, this interstitial flow imposes a physical drag on cancer cells that can activate mechanotransductive machinery and lead to directed cellular migration upstream of the flow in a process termed rheotaxis [29**]. These studies have provided valuable insights into how physical determinants can affect cancer cell migration.
Molecules in Mechanical Sensing
Sensing ECM properties
As we have discussed, physical properties and external forces from the cellular environment can drastically affect cell behavior. A fundamental question is thus how do cells sense these physical signals? To this end, integrins are important receptors involved in sensing the extracellular environment. Not only do they bind chemically to ECM ligands, but they also feel forces on the order of 1-40 pN for individual integrins, as measured with FRET sensors [30*,31**]. These forces are thought to originate from actinmyosin mediated tension [31], but cell membrane tension also plays a role during initial stages of adhesion [30*]. Moreover, it has become clear that differences in the binding strength of different types of integrins to ECM molecules are crucial for rigidity sensing [32]. Recent work has highlighted that the glycocalyx can also regulate integrin clustering and signaling, and is associated with increased cancer malignancy [33].
Intracellular molecules associated with integrins and adhesion complexes have also been implicated in force sensing. For instance, increasing ECM stiffness has been found to stabilize the vinculin-talin-actin complex, which increases PI3K signaling and leads to increased malignancy [34*]. Vinculin also plays a prominent role in F-actin regulation, adhesion formation and maturation, and ECM traction force organization in cell protrusions and migration [35]. These, and related intracellular mechanotransductive molecules, have also been implicated in migration in response to extracellular fluid flow [29].
Sensing neighboring cells
However, mechanotransductive signaling is not just limited to cell-ECM interactions, but also extends to cell-cell interactions as well. Here, E-cadherin is a major molecule involved in cell-cell coupling, and its downregulation in cancer has long been associated with the epithelial-mesenchymal transition, and subsequently, migratory and metastatic behavior [36,37]. More recent focus has been on the role of E-cadherin in force sensing and transmission. Using a FRET sensor, it was shown that the actin-myosin cytoskeleton constantly exerts forces on E-cadherin [38]. Surprisingly, E-cadherin feels these forces even outside of cell-cell contacts [38]. The link of E-cadherin to actin is facilitated by catenin molecules, and the strength of the resulting bond increases under applied force through what is termed a catch-bond [39*]. We anticipate that these intercellular forces play an important role in regulating processes such as EMT and/or collective cell migration, and future work will include quantitative measurements of cell-generated forces [38].
Cancer-associated alterations in cell mechanical properties
Interestingly, despite tumors being generally stiffer than comparable healthy tissue [7], individual cancer cells are typically softer than their healthy counterparts [40,41]. Whereas this increased stiffness is often attributed to increased ECM deposition in cancer, recent work has shown that cancer tissues have a bimodal distribution of stiffness, compared to unimodal distributions in healthy tissue, with the soft peak of the bimodal distribution corresponding to cells which, under hypoxia, exhibit high metastatic potential [42]. It is commonly believed that softness enables cells to migrate more easily through their environment. However, a simple classification into stiff or soft cells might not be sufficient to characterize a cell's ability to migrate. Hence, the focus is now shifting towards uncovering subcellular contributors to overall cell mechanics. For instance, nuclear stiffness, mediated by Lamins, can be rate limiting when cells migrate through confined environments [43]. Intermediate filaments stiffen the cytosol, but not the cortex [44], and their role in spreading and migration is an ongoing research topic [45]. Future work is needed to delineate more clearly the roles of the different subcellular compartments in cell mechanics.
Other cellular responses to mechanical signals
The transcription factors YAP (Yes-associated protein) and TAZ (transcriptional coactivator with PDZ-binding motif) have recently been implicated in transducing physical cues, such as matrix stiffness or cell size [46,47], into specific cellular responses, which include stiffness-dependent differentiation patterns [46], proliferation, cancer stem cell properties [48], resistance to anoikis [49] and metastasis [50]. Interestingly, YAP/TAZ signaling also acts as a memory in stem cell differentiation when extracellular stiffness is changed over time [51*]. Furthermore, YAP activity also plays a crucial role in the matrix stiffening and increased cancer invasion known to be facilitated through cancer associated fibroblasts (CAFs)[52]. Since, in turn, increased ECM stiffness is associated with increased YAP activity, [46], CAFs mediate a positive feedback loop of cell stiffness and YAP activity [52]. Likewise, there is crosstalk of YAP/TAZ with other important pathways implicated in cancer. For instance, Lamin-A and B, proteins associated with nuclear mechanics, are regulated by tissue elasticity, and subsequently regulate activity of YAP and SRF [53]. Moreover, β-catenin, a molecule known to have a dual role as both an intracellular messenger and a structural linker coupling Cadherins to the cytoskeleton, has been implicated in mediating crosstalk between YAP/TAZ and Wnt signaling [54,55]—a pathway known to be involved in regulating stem cell pluripotency during development and cell fate in cancer. Furthermore, it has recently been shown that a growing tumor can also affect β-catenin signaling in neighboring healthy cells due to the pressure exerted by the growing tumor [56**].
Migrating Cancer Stem Cells
Despite clear evidence showing the lethality resulting from cancer cell migration and metastasis, the exact mechanisms are still not completely understood. For example, there appears to be incongruent evidence showing that, while metastatic tumor formation is a relatively rare event, cancer cell invasion away from the primary tumor can occur early and often during tumor progression [57,58]. To explain this apparent paradox, some have proposed that only the migration of a rare and highly malignant subpopulation of tumor cells, the cancer stem cells (CSCs), can lead to the formation of tumors at distant metastatic sites [59]. Here, it is thought that the stem cell-defining capacity of self-renewal, which enables CSCs to proliferate indefinitely [60], is required to colonize the distant metastatic site.
Importantly, there is further evidence suggesting that CSCs may also have enhanced motility [61]. For example, in two recent studies that utilized fluorescent-based reporter systems to study CSC behavior in real-time, both studies found that cells identified as CSCs were more invasive within 3D matrices compared to their more differentiated counterparts [62,63]. Furthermore, the epithelial-mesenchymal transition (EMT), a key developmental program commonly activated during cancer invasion and metastasis, has been shown to generate CSCs [64,65]. Thus, the EMT cellular program may generate cancer cells that essentially pose a dual threat by exhibiting increased migration and the capacity to form new tumors.
In addition, investigations into the biophysical properties of both normal stem cells and CSCs have shown these cells to be significantly softer than their differentiated counterparts [66–68*]. For example, in a study that was able to isolate breast cancer cells based on their deformability, the most deformable cells were found to be correlated with a stem-like gene expression signature [69]. These findings raise the intriguing possibility that CSCs may be better able to migrate through their surrounding ECM due to their unique biophysical properties; namely their increased deformability. However, this hypothesis remains to be vigorously tested, and resolving this issue will rely on improved 3D culture models used in coordination with techniques rooted in biophysics and basic cancer biology. These findings motivate further investigations into the biochemical and biophysical mechanisms governing CSC migration, and could lead to an improved understanding of metastasis and the development of better therapies focused on targeting CSCs.
Future Directions
It has now been firmly established that physical cues from the tumor microenvironment play a fundamental role in tumor progression and metastasis. However, we are only beginning to understand the intricate details of the role of these forces. What exactly is causing these physical changes, and when do they arise in tumor progression? Moreover, is it possible, through therapeutic intervention, to revert these physical changes, and could this help to achieve a better prognosis?
The investigation of these questions will be greatly aided by the ongoing improvements of in vitro cell cultures. 3D cell cultures are increasingly becoming the norm, and recent breakthroughs have led to better independent control of physical properties, such as pore size and fibrous structure. Techniques able to control the physical ECM microenvironment will be combined with techniques capable of accurately controlling the ECM chemical composition, soluble growth factor concentrations, nutrient availability, and/or oxygen tension. Furthermore, these techniques should also be incorporated into co-culture assays that probe the interaction of cancer cells with stromal cells, immune cells or endothelial cells. In addition, similar to how mathematics has greatly accelerated progress in physics and traditional engineering, mathematical and computational approaches are increasingly capable of capturing biological complexity, and are becoming a third arm of biomedical research; aiding and complementing in vivo and in vitro experiments. We envisage that such new innovations—driven by collaborations between biologists, clinicians, engineers, physicists, mathematicians, and material scientists—will lead to novel high-throughput assays that can mimic various tumor microenvironments representing different tissues, different stages of tumor development, and different patients; and thus revolutionize both the basic understanding of tumor progression as well as drug screening and testing.
Figure 1. The tumor microenvironment.
The behavior of cancer cells is largely influenced by their environment. Hypoxia can induce epithelial-mesenchymal transition (EMT), stromal cells can release chemotactic growth factors, and cell-induced mechanical strains can realign ECM fibers. Moreover, these factors have been implicated with tumor progression, invasion, and metastasis. Furthermore, cells mediate considerable crosstalk between the environmental factors. For instance, in response to hypoxia, cells can stiffen the matrix through increased LOX expression. Additionally, tumor cells interact with fibroblasts causing the deposition of new ECM molecules, and physical forces from strains are associated with fiber alignment, leading to persistent migration and tissue invasion of cancer cells.
Figure 2. Intracellular signaling pathways integrate cell responses.
Cancer cells integrate a multitude of external signals to direct their responses. Besides well-established growth factor stimuli, for instance, LPA, which binds to G-protein coupled receptors (GPCR), physical forces also affect cell behavior. Cell-cell or cell-matrix adhesion molecules such as E-cadherin or integrins have a dual role: On the one hand, they provide structural support by linking the intracellular cytoskeleton with other cells or ECM, respectively. On the other hand, these molecules are also involved in signaling cascades, with a substantial overlap with the cascades mediated by growth factors. They, as well as some molecules binding to them, such as focal adhesion (FA) molecules, are constantly exposed to forces which, for instance, originate from myosin-mediated intracellular tension. Downstream of the cascades, molecules such as YAP integrate those different stimuli and direct transcriptional programs involved in proliferation, stem cell properties or metastasis.
Highlights (for review).
Physical cues from the tumor microenvironment strongly affect cancer cell behavior
Novel techniques increasingly help to capture those cues in vitro
Mechanisms for cellular force-sensing in process of being uncovered
New picture of the role of mechanics in cancer progression is emerging
Acknowledgments
We acknowledge the support of the NCI grant number 5U01CA177799 and NSF DMR Grant 1206635. Daniel S. Reynolds is supported by the National Science Foundation Graduate Research Fellowship under Grant No. DGE-1247312. Any opinion, findings, and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the National Science Foundation.
Footnotes
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
References
- 1.Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000;100:57–70. doi: 10.1016/s0092-8674(00)81683-9. [DOI] [PubMed] [Google Scholar]
- 2.Bissell MJ, Radisky DC, Rizki A, Weaver VM, Petersen OW. The organizing principle: Microenvironmental influences in the normal and malignant breast. Differentiation. 2002;70:537–546. doi: 10.1046/j.1432-0436.2002.700907.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Correia AL, Bissell MJ. The tumor microenvironment is a dominant force in multidrug resistance. Drug Resist. Updat. 2012;15:39–49. doi: 10.1016/j.drup.2012.01.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Östman A. Cancer-associated fibroblasts: Recent developments and emerging challenges. Semin. Cancer Biol. 2014;25:1–2. doi: 10.1016/j.semcancer.2014.02.004. [DOI] [PubMed] [Google Scholar]
- 5.de Visser KE, Eichten A, Coussens LM. Paradoxical roles of the immune system during cancer development. Nat Rev Cancer. 2006;6:24–37. doi: 10.1038/nrc1782. [DOI] [PubMed] [Google Scholar]
- 6.Bonnans C, Chou J, Werb Z. Remodelling the extracellular matrix in development and disease. Nat. Rev. Mol. Cell Biol. 2014;15:786–801. doi: 10.1038/nrm3904. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Paszek MJ, Zahir N, Johnson KR, Lakins JN, Rozenberg GI, Gefen A, Reinhart-King C a., Margulies SS, Dembo M, Boettiger D, et al. Tensional homeostasis and the malignant phenotype. Cancer Cell. 2005;8:241–254. doi: 10.1016/j.ccr.2005.08.010. [DOI] [PubMed] [Google Scholar]
- 8.Levental KR, Yu H, Kass L, Lakins JN, Egeblad M, Erler JT, Fong SFT, Csiszar K, Giaccia A, Weninger W, et al. Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling. Cell. 2009;139:891–906. doi: 10.1016/j.cell.2009.10.027. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9*.Chaudhuri O, Koshy ST, Branco da Cunha C, Shin J-W, Verbeke CS, Allison KH, Mooney DJ. Extracellular matrix stiffness and composition jointly regulate the induction of malignant phenotypes in mammary epithelium. Nat. Mater. 2014;13:1–35. doi: 10.1038/nmat4009. [An important step towards separating the effect of ECM properties such as stiffness and composition in tumor progression.] [DOI] [PubMed] [Google Scholar]
- 10.Zaman MH, Trapani LM, Sieminski AL, MacKellar D, Gong H, Kamm RD, Wells A, Lauffenburger DA, Matsudaira P. Migration of tumor cells in 3D matrices is governed by matrix stiffness along with cell-matrix adhesion and proteolysis. Proc. Natl. Acad. Sci. 2006;103:10889–10894. doi: 10.1073/pnas.0604460103. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Lo CM, Wang HB, Dembo M, Wang YL. Cell movement is guided by the rigidity of the substrate. Biophys. J. 2000;79:144–152. doi: 10.1016/S0006-3495(00)76279-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Raab M, Swift J, Dingal PCDP, Shah P, Shin JW, Discher DE. Crawling from soft to stiff matrix polarizes the cytoskeleton and phosphoregulates myosin-II heavy chain. J. Cell Biol. 2012;199:669–683. doi: 10.1083/jcb.201205056. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Bordeleau F, Tang LN, Reinhart-King C a. Topographical guidance of 3D tumor cell migration at an interface of collagen densities. Phys. Biol. 2013;10:065004. doi: 10.1088/1478-3975/10/6/065004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14**.Singh SP, Schwartz MP, Lee JY, Fairbanks BD, Anseth KS. A peptide functionalized poly(ethylene glycol) (PEG) hydrogel for investigating the influence of biochemical and biophysical matrix properties on tumor cell migration. Biomater. Sci. 2014;2:1024–1034. doi: 10.1039/C4BM00022F. [This study used peptide functionalized synthetic hydrogels to independently study the effect of various 3D matrix properties on cancer cell migration. The study also revealed the cell migration phenomenon of “reverse durotaxis”..] [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Provenzano PP, Eliceiri KW, Campbell JM, Inman DR, White JG, Keely PJ. Collagen reorganization at the tumor-stromal interface facilitates local invasion. BMC Med. 2006;4:38. doi: 10.1186/1741-7015-4-38. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16**.Riching KM, Cox BL, Salick MR, Pehlke C, Riching AS, Ponik SM, Bass BR, Crone WC, Jiang Y, Weaver AM, et al. 3D Collagen Alignment Limits Protrusions to Enhance Breast Cancer Cell Persistence. Biophys. J. 2014;107:2546–2558. doi: 10.1016/j.bpj.2014.10.035. [This work provided novel insights into how stiffness and fiber alignment affects cancer cell migration.] [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Aung A, Seo YN, Lu S, Wang Y, Jamora C, del Álamo JC, Varghese S. 3D Traction Stresses Activate Protease-Dependent Invasion of Cancer Cells. Biophys. J. 2014;107:2528–2537. doi: 10.1016/j.bpj.2014.07.078. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Wolf K, Mazo I, Leung H, Engelke K, Von Andrian UH, Deryugina EI, Strongin AY, Bröcker EB, Friedl P. Compensation mechanism in tumor cell migration: Mesenchymal-amoeboid transition after blocking of pericellular proteolysis. J. Cell Biol. 2003;160:267–277. doi: 10.1083/jcb.200209006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19**.Fraley SI, Wu P, He L, Feng Y, Krisnamurthy R, Longmore GD, Wirtz D. Three-dimensional matrix fiber alignment modulates cell migration and MT1-MMP utility by spatially and temporally directing protrusions. Sci. Rep. 2015;5:14580. doi: 10.1038/srep14580. [Provides novel insights into the relation between MMP activity, fiber alignment and migratory activity.] [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20*.Haeger A, Krause M, Wolf K, Friedl P. Cell jamming: Collective invasion of mesenchymal tumor cells imposed by tissue confinement. Biochim. Biophys. Acta - Gen. Subj. 2014;1840:2386–2395. doi: 10.1016/j.bbagen.2014.03.020. [Investigates how increased collagen concentration can induce a switch from single to collective cell migration.] [DOI] [PubMed] [Google Scholar]
- 21.Sharma Y, Vargas DA, Pegoraro AF, Lepzelter D, Weitz DA, Zaman M. Collective Motion of Mammalian Cell Cohorts in 3D. Integr. Biol. 2015 doi: 10.1039/c5ib00208g. doi:10.1039/C5IB00208G. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22**.Baker BM, Trappmann B, Wang WY, Sakar MS, Kim IL, Shenoy VB, Burdick JA, Chen CS. Cell-mediated fibre recruitment drives extracellular matrix mechanosensing in engineered fibrillar microenvironments. Nat. Mater. 2015 doi: 10.1038/nmat4444. doi:10.1038/nmat4444. [Developed a novel synthetic fibrous material with tunable mechanics and user-defined architecture. The work revealed that cells can probe their surroundings through fiber recruitment, a previously undescribed mechanism.] [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Sahlgren C, Gustafsson M V, Jin S, Poellinger L, Lendahl U. Notch signaling mediates hypoxia-induced tumor cell migration and invasion. Proc Natl Acad Sci U S A. 2008;105:6392–6397. doi: 10.1073/pnas.0802047105. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Gilkes DM, Semenza GL, Wirtz D. Hypoxia and the extracellular matrix: drivers of tumour metastasis. Nat. Rev. Cancer. 2014;14:430–9. doi: 10.1038/nrc3726. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Hofbauer KH, Gess B, Lohaus C, Meyer HE, Katschinski D, Kurtz A. Oxygen tension regulates the expression of a group of procollagen hydroxylases. Eur. J. Biochem. 2003;270:4515–4522. doi: 10.1046/j.1432-1033.2003.03846.x. [DOI] [PubMed] [Google Scholar]
- 26.Tse JR, Engler AJ. Stiffness Gradients Mimicking In Vivo Tissue Variation Regulate Mesenchymal Stem Cell Fate. PLoS One. 2011;6:e15978. doi: 10.1371/journal.pone.0015978. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Stylianopoulos T, Martin JD, Snuderl M, Mpekris F, Jain SR, Jain RK. Coevolution of Solid Stress and Interstitial Fluid Pressure in Tumors During Progression: Implications for Vascular Collapse. Cancer Res. 2013;73:3833–3841. doi: 10.1158/0008-5472.CAN-12-4521. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Milosevic M, Fyles a, Hedley D, Pintilie M, Levin W, Manchul L, Hill R. Interstitial fluid pressure predicts survival in patients with cervix cancer independent of clinical prognostic factors and tumor oxygen measurements. Cancer Res. 2001;61:6400–6405. [PubMed] [Google Scholar]
- 29**.Polacheck WJ, German AE, Mammoto A, Ingber DE, Kamm RD. Mechanotransduction of fluid stresses governs 3D cell migration. Proc. Natl. Acad. Sci. U. S. A. 2014;111:2447–52. doi: 10.1073/pnas.1316848111. [Gives new insights into how directed cell migration arises in response to fluid flow, and how this response is mediated through adhesion molecules.] [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30*.Wang X, Ha T. Defining single molecular forces required to activate integrin and notch signaling. Science. 2013;340:991–4. doi: 10.1126/science.1231041. [Introduced novel tension gauge tether technique to measure forces required to active integrin and notch signaling.] [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31**.Morimatsu M, Mekhdjian AH, Adhikari AS, Dunn AR. Molecular tension sensors report forces generated by single integrin molecules in living cells. Nano Lett. 2013;13:3985–3989. doi: 10.1021/nl4005145. [Introduces novel FRET-sensor based measurements of force distributions acting on individual integrin molecules.] [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Elosegui-Artola A, Bazellières E, Allen MD, Andreu I, Oria R, Sunyer R, Gomm JJ, Marshall JF, Jones JL, Trepat X, et al. Rigidity sensing and adaptation through regulation of integrin types. Nat. Mater. 2014;13:631–7. doi: 10.1038/nmat3960. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Paszek MJ, DuFort CC, Rossier O, Bainer R, Mouw JK, Godula K, Hudak JE, Lakins JN, Wijekoon AC, Cassereau L, et al. The cancer glycocalyx mechanically primes integrin-mediated growth and survival. Nature. 2014;511:319–25. doi: 10.1038/nature13535. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34*.Rubashkin MG, Cassereau L, Bainer R, DuFort CC, Yui Y, Ou G, Paszek MJ, Davidson MW, Chen Y-Y, Weaver VM. Force engages vinculin and promotes tumor progression by enhancing PI3K activation of phosphatidylinositol (3,4,5)-triphosphate. Cancer Res. 2014;74:4597–611. doi: 10.1158/0008-5472.CAN-13-3698. [Found that ECM stiffness per se can drive malignant transformation and metastasis through vinculin-mediated PI3K signaling.] [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Thievessen I, Thompson PM, Berlemont S, Plevock KM, Plotnikov S V, Zemljic-Harpf A, Ross RS, Davidson MW, Danuser G, Campbell SL, et al. Vinculin-actin interaction couples actin retrograde flow to focal adhesions, but is dispensable for focal adhesion growth. J. Cell Biol. 2013;202:163–177. doi: 10.1083/jcb.201303129. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Polyak K, Weinberg R a. Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat. Rev. Cancer. 2009;9:265–73. doi: 10.1038/nrc2620. [DOI] [PubMed] [Google Scholar]
- 37.Vargas D a, Bates O, Zaman MH. Computational model to probe cellular mechanics during epithelial-mesenchymal transition. Cells. Tissues. Organs. 2013;197:435–44. doi: 10.1159/000348415. [DOI] [PubMed] [Google Scholar]
- 38.Borghi N, Sorokina M, Shcherbakova OG, Weis WI, Pruitt BL, Nelson WJ, Dunn AR. E-cadherin is under constitutive actomyosin-generated tension that is increased at cell-cell contacts upon externally applied stretch. Proc. Natl. Acad. Sci. 2012;109:19034–19034. doi: 10.1073/pnas.1204390109. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39*.Buckley CD, Tan J, Anderson KL, Hanein D, Volkmann N, Weis WI, Nelson WJ, Dunn a. R. The minimal cadherin-catenin complex binds to actin filaments under force. Science (80−. ) 2014;346:1254211–1254211. doi: 10.1126/science.1254211. [Found a previously unknown catch-bond behavior for the catenin-mediated E-cadherin link to the actin cytoskeleton.] [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Guck J, Schinkinger S, Lincoln B, Wottawah F, Ebert S, Romeyke M, Lenz D, Erickson HM, Ananthakrishnan R, Mitchell D, et al. Optical deformability as an inherent cell marker for testing malignant transformation and metastatic competence. Biophys. J. 2005;88:3689–3698. doi: 10.1529/biophysj.104.045476. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Cross SE, Jin Y-S, Rao J, Gimzewski JK. Nanomechanical analysis of cells from cancer patients. Nat. Nanotechnol. 2007;2:780–783. doi: 10.1038/nnano.2007.388. [DOI] [PubMed] [Google Scholar]
- 42.Plodinec M, Loparic M, Monnier C a., Obermann EC, Zanetti-Dallenbach R, Oertle P, Hyotyla JT, Aebi U, Bentires-Alj M, Lim RYH, et al. The nanomechanical signature of breast cancer. Nat. Nanotechnol. 2012 doi: 10.1038/nnano.2012.167. doi:10.1038/nnano.2012.167. [DOI] [PubMed] [Google Scholar]
- 43.Harada T, Swift J, Irianto J, Shin J-W, Spinler KR, Athirasala A, Diegmiller R, Dingal PCDP, Ivanovska IL, Discher DE. Nuclear lamin stiffness is a barrier to 3D migration, but softness can limit survival. J. Cell Biol. 2014;204:669–682. doi: 10.1083/jcb.201308029. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Guo M, Ehrlicher AJ, Mahammad S, Fabich H, Jensen MH, Moore JR, Fredberg JJ, Goldman RD, Weitz D a. The role of vimentin intermediate filaments in cortical and cytoplasmic mechanics. Biophys. J. 2013;105:1562–1568. doi: 10.1016/j.bpj.2013.08.037. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Shabbir SH, Cleland MM, Goldman RD, Mrksich M. Geometric control of vimentin intermediate filaments. Biomaterials. 2014;35:1359–1366. doi: 10.1016/j.biomaterials.2013.10.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Dupont S, Morsut L, Aragona M, Enzo E, Giulitti S, Cordenonsi M, Zanconato F, Le Digabel J, Forcato M, Bicciato S, et al. Role of YAP/TAZ in mechanotransduction. Nature. 2011;474:179–183. doi: 10.1038/nature10137. [DOI] [PubMed] [Google Scholar]
- 47.Aragona M, Panciera T, Manfrin A, Giulitti S, Michielin F, Elvassore N, Dupont S, Piccolo S. A mechanical checkpoint controls multicellular growth through YAP/TAZ regulation by actin-processing factors. Cell. 2013;154:1047–1059. doi: 10.1016/j.cell.2013.07.042. [DOI] [PubMed] [Google Scholar]
- 48.Cordenonsi M, Zanconato F, Azzolin L, Forcato M, Rosato A, Frasson C, Inui M, Montagner M, Parenti AR, Poletti A, et al. The hippo transducer TAZ confers cancer stem cell-related traits on breast cancer cells. Cell. 2011;147:759–772. doi: 10.1016/j.cell.2011.09.048. [DOI] [PubMed] [Google Scholar]
- 49.Zhao B, Li L, Wang L, Wang CY, Yu J, Guan KL. Cell detachment activates the Hippo pathway via cytoskeleton reorganization to induce anoikis. Genes Dev. 2012;26:54–68. doi: 10.1101/gad.173435.111. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Lamar JM, Stern P, Liu H, Schindler JW, Jiang Z-G, Hynes RO. PNAS Plus: The Hippo pathway target, YAP, promotes metastasis through its TEAD-interaction domain. Proc. Natl. Acad. Sci. 2012;109:E2441–E2450. doi: 10.1073/pnas.1212021109. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51*.Yang C, Tibbitt MW, Basta L, Anseth KS. Mechanical memory and dosing influence stem cell fate. Nat. Mater. 2014;13:645–652. doi: 10.1038/nmat3889. [Uses novel technique to change matrix stiffness dynamically, and found that YAP/TAZ mediate cell responses depending on current and past mechanical properties.] [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Calvo F, Ege N, Grande-Garcia a, Hooper S, Jenkins RP, Chaudhry SI, Harrington K, Williamson P, Moeendarbary E, Charras G, et al. Mechanotransduction and YAP-dependent matrix remodelling is required for the generation and maintenance of cancer-associated fibroblasts. Nat Cell Biol. 2013;15:637–646. doi: 10.1038/ncb2756. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Swift J, Ivanovska IL, Buxboim A, Harada T, Dingal PCDP, Pinter J, Pajerowski JD, Spinler KR, Shin J-W, Tewari M, et al. Nuclear Lamin-A Scales with Tissue Stiffness and Enhances Matrix-Directed Differentiation. Science (80−. ) 2013;341:1240104–1240104. doi: 10.1126/science.1240104. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Azzolin L, Panciera T, Soligo S, Enzo E, Bicciato S, Dupont S, Bresolin S, Frasson C, Basso G, Guzzardo V, et al. YAP/TAZ incorporation in the β-catenin destruction complex orchestrates the Wnt response. Cell. 2014;158:157–170. doi: 10.1016/j.cell.2014.06.013. [DOI] [PubMed] [Google Scholar]
- 55.Rosenbluh J, Nijhawan D, Cox AG, Li X, Neal JT, Schafer EJ, Zack TI, Wang X, Tsherniak A, Schinzel AC, et al. beta -Catenin-driven cancers require a YAP1 transcriptional complex for survival and tumorigenesis. Cell. 2012;151:1457–1473. doi: 10.1016/j.cell.2012.11.026. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56**.Fernández-Sánchez ME, Barbier S, Whitehead J, Béalle G, Michel A, Latorre-Ossa H, Rey C, Fouassier L, Claperon A, Brullé L, et al. Mechanical induction of the tumorigenic β-catenin pathway by tumour growth pressure. Nature. 2015;523:92–95. doi: 10.1038/nature14329. [Found that mechanical pressure, such as originating from a growing tumor, can affect healthy tissue by inducing the β-catenin pathways.] [DOI] [PubMed] [Google Scholar]
- 57.Krishnamurthy S, Cristofanilli M, Singh B, Reuben J, Gao H, Cohen EN, Andreopoulou E, Hall CS, Lodhi A, Jackson S, et al. Detection of minimal residual disease in blood and bone marrow in early stage breast cancer. Cancer. 2010;116:3330–3337. doi: 10.1002/cncr.25145. [DOI] [PubMed] [Google Scholar]
- 58.Hüsemann Y, Geigl JB, Schubert F, Musiani P, Meyer M, Burghart E, Forni G, Eils R, Fehm T, Riethmüller G, et al. Systemic spread is an early step in breast cancer. Cancer Cell. 2008;13:58–68. doi: 10.1016/j.ccr.2007.12.003. [DOI] [PubMed] [Google Scholar]
- 59.Scheel C, Weinberg R a. Cancer stem cells and epithelial-mesenchymal transition: concepts and molecular links. Semin. Cancer Biol. 2012;22:396–403. doi: 10.1016/j.semcancer.2012.04.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60.Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF. Prospective identification of tumorigenic breast cancer cells. Proc. Natl. Acad. Sci. U. S. A. 2003;100:3983–8. doi: 10.1073/pnas.0530291100. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.Croker AK, Goodale D, Chu J, Postenka C, Hedley BD, Hess D a, Allan AL. High aldehyde dehydrogenase and expression of cancer stem cell markers selects for breast cancer cells with enhanced malignant and metastatic ability. J. Cell. Mol. Med. 2009;13:2236–52. doi: 10.1111/j.1582-4934.2008.00455.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62.Thiagarajan P, Hitomi M, Hale J, Alvarado A, Otvos B, Sinyuk M, Stoltz K, Wiechert A, Mulkearns-Hubert E, Jarrar A, et al. Development of a Fluorescent Reporter System to Delineate Cancer Stem Cells in Triple-Negative Breast Cancer. Stem Cells. 2015;33:2114–2125. doi: 10.1002/stem.2021. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63.Tang B, Raviv A, Esposito D, Flanders KC, Daniel C, Nghiem BT, Garfield S, Lim L, Mannan P, Robles AI, et al. A Flexible Reporter System for Direct Observation and Isolation of Cancer Stem Cells. Stem Cell Reports. 2015;4:155–169. doi: 10.1016/j.stemcr.2014.11.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64.Mani S a, Guo W, Liao M-J, Eaton EN, Ayyanan A, Campbell LL, Polyak K, Brisken C, Yang J, Weinberg R a, et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell. 2008;133:704–15. doi: 10.1016/j.cell.2008.03.027. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 65.Taube JH, Herschkowitz JI, Komurov K, Zhou AY, Gupta S, Yang J, Hartwell K, Onder TT, Gupta PB, Evans KW, et al. Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes. Proc. Natl. Acad. Sci. 2010;107:15449–15454. doi: 10.1073/pnas.1004900107. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66.Chowdhury F, Na S, Li D, Poh Y-C, Tanaka TS, Wang F, Wang N. Material properties of the cell dictate stress-induced spreading and differentiation in embryonic stem cells. Nat. Mater. 2010;9:82–88. doi: 10.1038/nmat2563. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 67.Liu J, Tan Y, Zhang H, Zhang Y, Xu P, Chen J, Poh Y-C, Tang K, Wang N, Huang B. Soft fibrin gels promote selection and growth of tumorigenic cells. Nat. Mater. 2012;11:734–741. doi: 10.1038/nmat3361. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 68*.Tan Y, Tajik A, Chen J, Jia Q, Chowdhury F, Wang L, Chen J, Zhang S, Hong Y, Yi H, et al. Matrix softness regulates plasticity of tumour-repopulating cells via H3K9 demethylation and Sox2 expression. Nat. Commun. 2014;5:4619. doi: 10.1038/ncomms5619. [Showed that soft 3D fibrin environments promote a stem-like phenotype in melanoma cells through H3K9 demethylation and increased expression of the stem-related Sox2 transcription factor.] [DOI] [PMC free article] [PubMed] [Google Scholar]
- 69.Zhang W, Kai K, Choi DS, Iwamoto T, Nguyen YH, Wong H, Landis MD, Ueno NT, Chang J, Qin L. Microfluidics separation reveals the stem-cell-like deformability of tumor-initiating cells. Proc. Natl. Acad. Sci. U. S. A. 2012;109:18707–12. doi: 10.1073/pnas.1209893109. [DOI] [PMC free article] [PubMed] [Google Scholar]



